Fast, local cryopreservation is a consistent bottleneck for autologous cell therapy developers, even in major cell and gene therapy hubs. For the peripheral blood mononuclear cells (PBMCs) that form ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results